Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A man carries a Confederate flag outside the U.S. Senate Chamber on Jan. 6. Photo: Saul Loeb/AFP via Getty Images

Democrats in the Senate are looking to officially condemn the acts of Jan 6. by drafting a resolution expressing contempt for violent white supremacists, neo-Nazis, anti-government militias and fringe conspiracy theories.

Why it matters: The resolution is the first official measure to denounce last month's insurrection that resulted in five deaths and the second impeachment of former President Trump. It is unclear if it will receive a vote before his trial, or even be brought to the floor for debate.

The resolution also calls on the FBI and the U.S. intelligence community to conduct a review of any targeting and recruitment of former and current U.S. military and law enforcement into domestic terrorist groups.

  • At least 27 of the 140 of those charged in the Capitol riots have served or currently serve in the military, NPR reports.

That investigation would include a review of the use of social media to recruit members and engage in acts of violence, investigate sources of funding for domestic terrorists and the coordination of such groups with foreign actors, the resolution states.

The details: Democrats will introduce the resolution Tuesday, one week ahead of former Trump’s trial on the charges of “incitement of the insurrection.”

  • Sen. Martin Heinrich (D-N.M.) is lead sponsor.
  • Majority Leader Chuck Schumer of New York and nine other Democrats have signed onto it, including Sens. Patrick Leahy of Vermont, Ron Wyden of Oregon, Dick Durbin of Illinois, Jack Reed of Rhode Island, Sherrod Brown of Ohio, Richard Blumenthal of Connecticut, Tammy Baldwin of Wisconsin, Tammy Duckworth of Illinois and Cory Booker of New Jersey.
  • No Republicans have been asked to serve as cosponsors, a Schumer spokesperson told Axios.

Flashback: Both the House and Senate passed, and President Trump later signed, a joint resolution condemning the acts of white supremacists and neo-Nazis during the Charlottesville, Va., protest and violence in August 2017.

Go deeper

Jan 31, 2021 - Politics & Policy

Trump announces new legal team for second impeachment trial

Photo: Mandel Ngan/AFP via Getty Images

Former President Trump announced on Sunday that lawyers David Schoen and Bruce L. Castor Jr. will lead his defense at his upcoming impeachment trial.

Why it matters: The hiring comes a day after news broke that South Carolina lawyers Butch Bowers and Deborah Barbier had left the team, due in part to the fact that Trump wanted them to argue the election was stolen rather than focus on the constitutionality of the trial, CNN reported.

Biden explains justification for Syria strike in letter to Congress

Photo: Chris Kleponis/CNP/Bloomberg via Getty Images

President Biden told congressional leadership in a letter Saturday that this week's airstrike against facilities in Syria linked to Iranian-backed militia groups was consistent with the U.S. right to self-defense.

Why it matters: Some Democrats, including Sens. Tim Kaine (D-Va.) and Chris Murphy (D-Conn.) and Rep. Ro Khanna (D-Calif.), have criticized the Biden administration for the strike and demanded a briefing.

5 hours ago - Health

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

Photo: Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!